Choose Language
Select a language for news translation.
Eli Lilly’s stock hit a record high after Europe endorsed its leukemia drug Jaypirca and Medicare agreed to cover its weight-loss drugs Zepbound and Mounjaro, …
Oleksandr Usyk vacated his WBA, WBC, and IBF heavyweight titles without retiring, leaving the division open for contenders like Agit Kabayel and Daniel Dubois.…
A Michigan couple faces charges after their 7-year-old son, weighing 255 pounds, died from severe neglect with only one doctor visit, while they prioritized ve…
Promoter Eddie Hearn claims he's "never been more confident" Anthony Joshua will knock out Tyson Fury in their heavyweight rematch on December 8. Hearn's confi…
The FCC received over 50,000 public comments about its investigation into *The View* for potential indecency rule violations, a rare probe sparked by a single …
GLP-1 drugs like Ozempic and Wegovy help average 15% fat loss, but up to 30% see less than 5% weight loss after six months; poor sleep, medications, and geneti…
Insurers are dropping coverage for weight-loss drugs like Zepbound and Wegovy due to high costs, leaving 24 million Americans without access by 2026. Coverage …
(RTTNews) - Shares of Alphabet Inc. (GOOG) tumbled nearly 7% on Monday, setting up for its worst daily drop in about a year. This downturn comes as investors r…
Voters in Maryland are weighing in on a slate of House primary elections Tuesday. Rep. Steny Hoyer’s (D-Md.) retirement has opened the seat representing the 5t…
What to do if your insurance denies your obesity drug.
Tyson Fury’s heavyweight super-fight with Anthony Joshua is not in danger of collapse, insists Frank Warren.
